Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Peter Morgan Kash
AddedMar 31, 2024
UpdatedMay 1, 2026
Peter Morgan Kash

Peter Morgan Kash

Board Member, Riverbank Capital Securities

Peter Morgan Kash's Career

Riverbank Capital Securities
Riverbank Capital Securities

New York City, NY, US

Board Member· Board
Kirax
Kirax

Bonita Springs, FL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Peter Morgan Kash's Career

Riverbank Capital Securities
Riverbank Capital Securities
Investment FirmInvestment Firm52004New York City, NY, US
Board Member· Board

Leadership at Riverbank Capital Securities

Joshua KazamJoshua KazamBoard Member

Similar to Riverbank Capital Securities

SI SecuritiesSI SecuritiesNew York City, NY, USest. 2013SI SecuritiesNew York City, NY, US · est. 2013

SI Securities, LLC: Expert financial brokerage firm specializing in trading stocks, bonds, and mutual funds.

Investment Firm30
Bank of America SecuritiesBank of America SecuritiesNew York City, NY, USBank of America SecuritiesNew York City, NY, US

Bank of America Securities: Investment banking subsidiary offering trading, brokerage services.

Investment Firm10k
Javcap SecuritiesJavcap SecuritiesNew York City, NY, USest. 2006Javcap SecuritiesNew York City, NY, US · est. 2006

NYC-based Alternative Investment Services, LLC specializes in financial brokerage and trading securities.

Investment Firm15
Flying Cloud SecuritiesFlying Cloud SecuritiesSan Francisco, CA, USest. 2013Flying Cloud SecuritiesSan Francisco, CA, US · est. 2013

Flying Cloud Securities LLC: Specialized financial brokerage for stocks, bonds, and mutual funds.

Investment Firm2
Kirax
Kirax
Public$540.8k62012Bonita Springs, FL, US
Board Member· Board

Leadership at Kirax

Neil FlanzraichNeil FlanzraichCEO
Edmundo MunizEdmundo MunizFounder

Similar to Kirax

Tigris PharmaceuticalsTigris PharmaceuticalsBonita Springs, FL, USCancer Treatmentsest. 2005Tigris PharmaceuticalsBonita Springs, FL, US · est. 2005

Tigris Pharmaceuticals: Innovating biopharmaceutical solutions for cancer and other medical needs.

Series C · $32.5M6
Karyopharm TherapeuticsKaryopharm TherapeuticsNewton, MA, USPharmaceuticalsest. 2008Karyopharm TherapeuticsNewton, MA, US · est. 2008

US-based Karyopharm Therapeutics offers oncology-focused pharmaceutical solutions, specializing in multiple myeloma treatments.

Public · $546.7M385
Kira PharmaceuticalsKira PharmaceuticalsCambridge, MA, USBiotechnology, Therapeuticsest. 2017Kira PharmaceuticalsCambridge, MA, US · est. 2017

Kira Pharmaceuticals: A global biotech leader, pioneering in complement disease therapies, with a robust pipeline.

Series B · $99.5M27

Peter Morgan Kash's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Peter Morgan Kash

Peter S KastnerPeter S KastnerBoard Member · Ariel Southeast Angel PartnersPeter C KennyPeter C KennyBoard Member · Bank OZKPeter KaiserPeter KaiserBoard Member · Quark PharmaceuticalsPeter KjærPeter KjærBoard Member · CapnovaRobert M CashillRobert M CashillBoard Member · Investors BankPeter H KaminPeter H KaminBoard Member · Tile Shop Holdings